Code Medical Apps
The Brigham and Dana-Farber Board Review in Hematology and Oncology
Image

The Brigham and Dana-Farber Board Review in Hematology and Oncology

(0) 0 reviews
$20.00
31,300 IQD
Buy & Earn 5 $ credit
$30.0033% OFF

Format: 58 Videos File Size: 9.8 GB Edition: 2018

Product Details & Options

Choose your preferences from the options below.

No additional product details available.

Quantity:
1

Product Tags

About This Product

Comprehensive 2018 Brigham and Dana-Farber Hematology and Oncology Board Review covering leukemia, lymphoma, solid tumors, benign hematology, transfusion medici

Product Overview

Description 

Format: 58 Videos
File Size: 9.8 GB
Edition: 2018

1. Molecular and Transplantation

  • Molecular Genetics of Cancer — Nikhil Wagle, MD

  • Advances in Cancer Drug Development — Geoffrey I. Shapiro, MD, PhD

  • Infections in Cancer Patients — Lindsey Baden, MD

  • Symptom Management in Patients with Cancer — Janet L. Abrahm, MD

  • Communication: End-of-Life Care — Susan D. Block, MD

  • Hematopoietic Stem Cell Transplantation — Robert J. Soiffer, MD

  • Acute Leukemia & Myelodysplastic Syndromes — Benjamin L. Ebert, MD, PhD

  • Acute Leukemias — Daniel J. DeAngelo, MD, PhD

  • Myelodysplastic Syndrome — David P. Steensma, MD

  • Chronic Myelogenous Leukemia — Joseph H. Antin, MD

  • Myeloproliferative Syndromes — Ann M. Mullally, MD


2. Hematologic Malignancies

  • Multiple Myeloma — Kenneth C. Anderson, MD

  • Waldenstrom Macroglobulinemia, Amyloidosis — Irene M. Ghobrial, MD

  • Low Grade Lymphomas — Caron A. Jacobson, MD

  • High Grade Lymphomas — Eric D. Jacobsen, MD

  • Hodgkin’s Lymphoma — Ann S. LaCasce, MD

  • CLL and B Cell Malignancies — Matthew S. Davids, MD


3. Solid Tumors: Head, Lung, Endocrine, GI

  • Head and Neck Cancer — Robert I. Haddad, MD

  • Natural History, Screening, Surgery, Small Cell Lung Cancer — Bruce E. Johnson, MD

  • Non Small Cell Lung Cancer — Mark Awad, MD, PhD

  • Mesothelioma and Thymoma — David M. Jackman, MD

  • Thyroid Cancer — Jochen Lorch, MD

  • Carcinoid and Pancreatic Neuroendocrine Tumors — Jennifer Ang Chan, MD

  • Esophageal and Gastric Cancer — Peter C. Enzinger, MD

  • Pancreatic and Hepatobiliary Cancer — Brian M. Wolpin, MD

  • Anal Cancers — Robert J. Mayer, MD

  • Colorectal Cancers — Robert J. Mayer, MD

  • GI Genetic Syndromes — Matthew Yurgelun, MD


4. Genitourinary, Melanoma, Sarcoma, GYN, CNS

  • Germ Cell Tumor — Mark M. Pomerantz, MD

  • Renal and Bladder Cancer — Toni K. Choueiri, MD

  • Prostate Cancer Part I — Atish Choudhury, MD, PhD

  • Prostate Cancer Part II — Atish Choudhury, MD, PhD

  • Melanoma — F. Stephen Hodi, MD

  • Sarcomas and GIST — George D. Demetri, MD

  • Ovarian Cancer — Ursula A. Matulonis, MD

  • Cervical and Endometrial Cancer — Panagiotis A. Konstantinopoulos, MD, PhD

  • Neuro-oncology — David A. Reardon, MD


5. Breast Cancer

  • Breast Cancer: Risk Factors, Genetics, Screening and Prevention — Judy E. Garber, MD, MPH

  • Breast Cancer: Staging, Prognosis, Surgery and Radiation, DCIS — Harold J. Burstein, MD, PhD

  • HER2-Positive and Triple Negative Breast Cancer — Eric P. Winer, MD

  • Breast Cancer Survivorship — Ann H. Partridge, MD, MPH


6. Benign Hematology

  • Hematopoiesis and Cytokines — David T. Scadden, MD

  • Acquired Bone Marrow Failure — Julie-Aurore Losman, MD, PhD

  • Congenital Bone Marrow Failure — David A. Williams, MD

  • Hemophagocytic Syndromes and Immunodeficiencies — Barbara A. Degar, MD

  • Anemia Overview — Ronald P. McCaffrey, MD

  • Iron Deficiency and Iron Overload — Mark D. Fleming, MD, PhD

  • Immune Hemolytic Anemia — Richard M. Kaufman, MD

  • Non-immune Hemolytic Anemia — David E. Golan, PhD, MD

  • Sickle Cell Disease — Maureen M. Achebe, MD, MPH

  • Thalassemia and Hemoglobinopathies — Matthew M. Heeney, MD

  • Disorders of Neutrophils — Nancy Berliner, MD

  • Acquired Thrombocytopenias — Elisabeth M. Battinelli, MD, PhD

  • Hemophilia — Aric D. Parnes, MD

  • Von Willebrand and Platelet Disorders — Nathan T. Connell, MD, MPH

  • Thrombophilia — Kenneth A. Bauer, MD

  • New Oral Anticoagulants — Jean M. Connors, MD

  • Transfusion Medicine — Walter H. Dzik, MD

     

Product FAQ & Details

Frequently Asked Questions About The Brigham and Dana-Farber Board Review in Hematology and Oncology

Find essential details on file delivery, device compatibility, examination relevance, and academic support for this medical resource.

What materials and content formats are included with The Brigham and Dana-Farber Board Review in Hematology and Oncology?

The Brigham and Dana-Farber Board Review in Hematology and Oncology includes comprehensive high-definition video lectures, companion PDF syllabus notes, and clinical slides. All learning modules and review materials are organized systematically to support both quick reference and thorough examination preparation.

Explore related Physicians (MD) products

How quickly do I get access to The Brigham and Dana-Farber Board Review in Hematology and Oncology after completing my order?

Access is granted immediately upon order confirmation. You will receive direct links and instructions in your user profile under the Orders section and via email confirmation, enabling you to start learning without delay.

View your account orders

Is The Brigham and Dana-Farber Board Review in Hematology and Oncology suitable for board exam preparation and continuing medical education?

Yes. This resource is curated to reflect current clinical guidelines and high-yield examination objectives for medical students, residents, and practicing specialists preparing for licensing, specialty boards, or clinical knowledge updates.

Browse board review resources

Can I access The Brigham and Dana-Farber Board Review in Hematology and Oncology on multiple devices (iPad, iPhone, Android, PC, Mac)?

Yes. The materials are fully compatible with modern operating systems and mobile devices. You can stream lectures or download supplementary PDFs to your tablet, laptop, or smartphone for convenient offline study.

Learn about digital compatibility

What support is available if I need assistance with The Brigham and Dana-Farber Board Review in Hematology and Oncology?

Our dedicated medical support team is on standby via WhatsApp, live chat, and email to assist you with order verification, download questions, or study guidance.

Contact medical support

Are the clinical guidelines and recommendations in The Brigham and Dana-Farber Board Review in Hematology and Oncology up to date?

Yes. We ensure all medical titles and course recordings are sourced from the latest official curriculum revisions and accredited academic medical institutions.

Learn about our quality standards
100% Verified Content
Instant Digital Access
Secure Checkout
Dedicated Support
The Brigham and Dana-Farber Board Review in Hematology and Oncology